Clinical site monitoring in human subjects, baltimore, MD. (riva study)
Ended Awarded Last action
- Contract number
- 75F40119F19014
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $7,053
Award facts
- Opportunity
-
- FDASOL1185780 Solicitation number
- Contract value 100% obligated
- $7,052.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21250, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,089 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $9,141 |
About this award
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to The Emmes Company LLC, a global clinical research organization based in Potomac, Maryland. The contract, valued at $7,052.63, is for clinical site monitoring services in support of the RIVA study in Baltimore, Maryland. The award does not have a set-aside designation.
The Emmes Company LLC is an experienced provider of comprehensive research support services to federal agencies, particularly the National Institutes of Health (NIH). The company has secured numerous prime contracts and grants from various NIH institutes, demonstrating expertise across a broad spectrum of research domains including infectious diseases, oncology, transplantation, and rare diseases. Emmes also holds several significant federal contract Indefinite Delivery Vehicles (IDVs) that facilitate its ongoing support of government research initiatives, such as the $545 million Comprehensive and Rapid Response for NIAID Research Programs contract.
Quick answers
Who was awarded contract 75F40119F19014?
75F40119F19014 was awarded to The Emmes Company, LLC by Food and Drug Administration (Department of Health and Human Services) on July 24, 2019.
How much is contract 75F40119F19014 worth?
The government has obligated $7,053 on 75F40119F19014.
Is contract 75F40119F19014 an order under another contract?
Yes. 75F40119F19014 is a delivery order under HHSF223201710031I, an indefinite delivery contract.
Was contract 75F40119F19014 competed?
The extent of competition for 75F40119F19014 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award